The Federal Trade Commission says that claim is bogus and that the New Jersey-based company misled consumers by suggesting the formula was the first to meet government approval for reducing the risk of allergies.
By ANNE FLAHERTY, Associated Press, San Francisco Chronicle
Thu, 10/30/2014 - 8:55am
The Federal Trade Commission says that claim is bogus and that the New Jersey-based company misled consumers by suggesting the formula was the first to meet government approval for reducing the risk of allergies.